This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Quaker Chemical (KWR) Q2 Earnings Lag Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of -6.04% and +4.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Linde (LIN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Linde (LIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Quaker Chemical (KWR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quaker Chemical (KWR) Reliance on International Sales: What Investors Need to Know
by Zacks Equity Research
Evaluate Quaker Chemical's (KWR) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Compared to Estimates, Quaker Chemical (KWR) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Quaker Chemical (KWR) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Quaker Chemical (KWR) Tops Q1 Earnings Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of 3.95% and 2.90%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Will Green Plains Renewable Energy (GPRE) Report Negative Q1 Earnings? What You Should Know
by Zacks Equity Research
Green Plains (GPRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Quaker Chemical (KWR) Q1 Earnings Expected to Decline
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Strength Seen in Quaker Chemical (KWR): Can Its 14.4% Jump Turn into More Strength?
by Zacks Equity Research
Quaker Chemical (KWR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
KWR Wraps Up Dipsol Chemicals Buyout & Announces Natech Acquisition
by Zacks Equity Research
Dipsol and Natech strengthen Quaker Chemical's position in their respective markets and product technologies.
KWR Acquires Dipsol Chemicals to Boost Portfolio of Advanced Solutions
by Zacks Equity Research
Quaker Chemical is set to offer advanced solutions by using Dipsol's product technologies and its end markets.
Investing in Quaker Chemical (KWR)? Don't Miss Assessing Its International Revenue Trends
by Zacks Equity Research
Explore how Quaker Chemical's (KWR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Quaker Chemical's Q4 Earnings Lag Estimates, Revenues Beat
by Zacks Equity Research
KWR's sales decline in Q4 due to lower selling prices, unfavorable currency swings and reduced organic sales volumes.
Here's What Key Metrics Tell Us About Quaker Chemical (KWR) Q4 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Quaker Chemical (KWR) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Quaker Chemical (KWR) Misses Q4 Earnings Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of -17.90% and 0.54%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
AdvanSix (ASIX) Q4 Earnings Beat Estimates
by Zacks Equity Research
AdvanSix (ASIX) delivered earnings and revenue surprises of 124.32% and 12.75%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Exploring Analyst Estimates for Quaker Chemical (KWR) Q4 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Quaker Chemical (KWR), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
Celanese (CE) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Celanese (CE) delivered earnings and revenue surprises of 20.83% and 3.03%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Quaker Chemical (KWR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quaker Chemical (KWR) International Revenue Performance Explored
by Zacks Equity Research
Examine the evolution of Quaker Chemical's (KWR) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Compared to Estimates, Quaker Chemical (KWR) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Quaker Chemical (KWR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Quaker Chemical (KWR) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Quaker Chemical (KWR) delivered earnings and revenue surprises of -7.35% and 1.31%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Quaker Chemical (KWR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Flexible Solutions (FSI) Q2 Earnings & Sales Top Estimates
by Zacks Equity Research
Flexible Solutions' (FSI) Biodegradable Polymers sales rise in Q2 on higher customer orders.
American Vanguard (AVD) Q2 Earnings and Sales Miss Estimates
by Zacks Equity Research
Unfavorable market conditions weigh on American Vanguard's (AVD) top line in the second quarter.